KLHL13
Basic information
Region (hg38): X:117897813-118117340
Previous symbols: [ "BKLHD2", "KIAA1309" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KLHL13 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 9 | |||||
missense | 10 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 9 | 7 | 3 |
Variants in KLHL13
This is a list of pathogenic ClinVar variants found in the KLHL13 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-117898954-T-C | not specified | Uncertain significance (Apr 22, 2024) | ||
X-117898961-G-C | not specified | Uncertain significance (Nov 03, 2023) | ||
X-117899103-C-T | Likely benign (Apr 01, 2022) | |||
X-117899319-C-T | Likely benign (Apr 01, 2022) | |||
X-117899320-G-A | not specified | Uncertain significance (Jul 13, 2022) | ||
X-117901897-G-A | Likely benign (Aug 01, 2022) | |||
X-117909563-C-T | Benign (Dec 20, 2017) | |||
X-117909566-A-G | Likely benign (Apr 01, 2023) | |||
X-117909589-G-A | not specified | Uncertain significance (Aug 17, 2022) | ||
X-117909608-C-G | Benign (Dec 20, 2018) | |||
X-117909659-C-T | Likely benign (Apr 05, 2018) | |||
X-117909774-G-A | not specified | Uncertain significance (Jan 31, 2022) | ||
X-117909885-G-C | not specified | Uncertain significance (Jul 28, 2021) | ||
X-117909941-G-A | Benign (Dec 31, 2019) | |||
X-117919523-C-A | not specified | Uncertain significance (May 09, 2023) | ||
X-117919684-T-C | not specified | Uncertain significance (Jan 17, 2024) | ||
X-117920314-A-G | Likely benign (Apr 01, 2022) | |||
X-117920363-T-G | not specified | Uncertain significance (Mar 16, 2022) | ||
X-117945498-T-C | not specified | Uncertain significance (Jan 23, 2023) | ||
X-117945517-C-T | not specified | Uncertain significance (Apr 29, 2024) | ||
X-118028424-C-T | Likely benign (Jan 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KLHL13 | protein_coding | protein_coding | ENST00000539496 | 8 | 219528 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0350 | 0.964 | 125725 | 4 | 6 | 125735 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.20 | 157 | 256 | 0.612 | 0.0000195 | 4356 |
Missense in Polyphen | 46 | 96.313 | 0.47761 | 1544 | ||
Synonymous | 0.733 | 83 | 91.9 | 0.903 | 0.00000710 | 1237 |
Loss of Function | 2.78 | 6 | 19.1 | 0.313 | 0.00000147 | 346 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000305 | 0.000246 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000624 | 0.0000440 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000525 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex required for mitotic progression and cytokinesis. The BCR(KLHL9-KLHL13) E3 ubiquitin ligase complex mediates the ubiquitination of AURKB and controls the dynamic behavior of AURKB on mitotic chromosomes and thereby coordinates faithful mitotic progression and completion of cytokinesis. {ECO:0000269|PubMed:14528312, ECO:0000269|PubMed:17543862, ECO:0000269|PubMed:19995937}.;
- Pathway
- Ubiquitin mediated proteolysis - Homo sapiens (human);Post-translational protein modification;Metabolism of proteins;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Neddylation;Aurora B signaling
(Consensus)
Recessive Scores
- pRec
- 0.0909
Intolerance Scores
- loftool
- 0.514
- rvis_EVS
- -0.23
- rvis_percentile_EVS
- 37.32
Haploinsufficiency Scores
- pHI
- 0.266
- hipred
- Y
- hipred_score
- 0.866
- ghis
- 0.467
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.968
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Klhl13
- Phenotype
Gene ontology
- Biological process
- cell cycle;protein ubiquitination;regulation of cytokinesis;post-translational protein modification;cell division
- Cellular component
- cytosol;midbody;Cul3-RING ubiquitin ligase complex
- Molecular function
- ubiquitin-protein transferase activity